Publication | Closed Access

Chronic treatment with Δ9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

Substance UseCannabinoid PharmacologyAddiction MedicinePsychoactive Substance UseDrug AddictionHealth SciencesCannabis Useδ9-Tetrahydrocannabinol EnhancesPsychoactive DrugBehavioral NeuroscienceAddiction TreatmentBehavioral PharmacologyNeuropharmacologyPharmacologyCannabisSubstance AbuseAddictionNeuroscienceMedicineChronic Treatment